328 related articles for article (PubMed ID: 32216649)
1. Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients.
Lin RJ; Cohen AG; Stabler SM; Devlin SM; Elko TA; Maloy MA; Korc-Grodzicki B; Alexander K; Kramer D; Sanchez-Escamilla M; Castillo Flores N; Barker JN; Cho C; Dahi PB; Gyurkocza B; Papadopoulos EB; Perales MA; Politikos I; Ponce DM; Sauter CS; Scordo M; Shaffer BC; Shah GL; Tamari R; Young JW; Jakubowski AA; Giralt SA; Nelson JE
J Palliat Med; 2020 Dec; 23(12):1653-1657. PubMed ID: 32216649
[No Abstract] [Full Text] [Related]
2. Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients.
Obeid KM; Sapkota S; Cao Q; Richmond S; Watson AP; Karadag FK; Young JH; Pruett T; Weisdorf DJ; Ustun C
Transpl Infect Dis; 2022 Feb; 24(1):e13720. PubMed ID: 34455662
[TBL] [Abstract][Full Text] [Related]
3. Integration of Palliative Care in Hematopoietic Cell Transplant: Pediatric Patient and Parent Needs and Attitudes.
Levine DR; Epperly R; Collins G; Talleur AC; Mandrell B; Pritchard M; Sarvode Mothi S; Li C; Lu Z; Baker JN
J Pain Symptom Manage; 2023 Sep; 66(3):248-257. PubMed ID: 37302531
[TBL] [Abstract][Full Text] [Related]
4. Advance Directive Utilization Is Associated with Less Aggressive End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Cappell K; Sundaram V; Park A; Shiraz P; Gupta R; Jenkins P; Periyakoil VSJ; Muffly L
Biol Blood Marrow Transplant; 2018 May; 24(5):1035-1040. PubMed ID: 29371107
[TBL] [Abstract][Full Text] [Related]
5. End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Salazar MM; DeCook LJ; Butterfield RJ; Zhang N; Sen A; Wu KL; Vanness DJ; Khera N
J Palliat Med; 2022 Jan; 25(1):97-105. PubMed ID: 34705545
[No Abstract] [Full Text] [Related]
6. Characteristics, interventions, and outcomes of lung transplant recipients co-managed with palliative care.
Colman R; Singer LG; Barua R; Downar J
J Palliat Med; 2015 Mar; 18(3):266-9. PubMed ID: 25162457
[TBL] [Abstract][Full Text] [Related]
7. Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States.
McGuirk J; Divine C; Moon SH; Chandak A; Zhang Z; Papanicolaou GA
Transplant Cell Ther; 2021 Jun; 27(6):505.e1-505.e9. PubMed ID: 33775616
[TBL] [Abstract][Full Text] [Related]
8. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
[TBL] [Abstract][Full Text] [Related]
9. Quality-of-Life Trajectories in Adolescent and Young Adult versus Older Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
Mathanda RR; Hamilton BK; Rybicki L; Advani AS; Colver A; Dabney J; Ferraro C; Hanna R; Kalaycio M; Lawrence C; McLellan L; Sobecks R; Majhail NS; Rotz SJ
Biol Blood Marrow Transplant; 2020 Aug; 26(8):1505-1510. PubMed ID: 32439476
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of pre-transplant frailty and mental distress in hematopoietic cell transplantation and association with clinical outcomes.
Singh S; Cao Q; Demorest C; He F; Kramer A; Holtan S; Juckett M; Ramesh V; Arora M; Maakaron J; Weisdorf D; Jurdi NE
Transplant Cell Ther; 2024 Jun; ():. PubMed ID: 38838780
[TBL] [Abstract][Full Text] [Related]
11. Real-World Economic Burden Associated with Transplantation-Related Complications.
Perales MA; Bonafede M; Cai Q; Garfin PM; McMorrow D; Josephson NC; Richhariya A
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1788-1794. PubMed ID: 28688917
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation.
Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1711-1718. PubMed ID: 32194285
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prolonged magnesium infusion after allogeneic hematopoietic cell transplant.
Seago K; Goodner JA; Dillaman M; Wen S; Veltri L; Ross KG; Cumpston A
Support Care Cancer; 2023 Dec; 32(1):49. PubMed ID: 38129335
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic Cell Transplant (HCT) in the Elderly: Myths, Controversies and Unknowns.
Al-Mansour Z; Ramanathan M; Cerny J
Drugs Aging; 2018 Dec; 35(12):1055-1064. PubMed ID: 30302674
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients.
Keller JW; Andreadis C; Damon LE; Kaplan LD; Martin TG; Wolf JL; Ai WZ; Venstrom JM; Smith CC; Gaensler KM; Hwang J; Olin RL
J Geriatr Oncol; 2014 Jul; 5(3):238-44. PubMed ID: 24894413
[TBL] [Abstract][Full Text] [Related]
16. Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell Transplantation.
Epperla N; Hamadani M; Ahn KW; He F; Kodali D; Kleman A; Hari PN; Pasquini M; Fenske TS; Craig MD; Kanate AS; Bachanova V
Biol Blood Marrow Transplant; 2018 May; 24(5):983-988. PubMed ID: 29410340
[TBL] [Abstract][Full Text] [Related]
17. Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients.
Heybati K; Ochal D; Hogan W; Al-Khateeb H; Sklar D; Herasevich S; Litzow M; Shah M; Torghabeh MH; Durani U; Bauer P; Gajic O; Yadav H
Ann Hematol; 2024 Mar; 103(3):957-967. PubMed ID: 38170240
[TBL] [Abstract][Full Text] [Related]
18. Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
El-Jawahri A; LeBlanc T; VanDusen H; Traeger L; Greer JA; Pirl WF; Jackson VA; Telles J; Rhodes A; Spitzer TR; McAfee S; Chen YA; Lee SS; Temel JS
JAMA; 2016 Nov; 316(20):2094-2103. PubMed ID: 27893130
[TBL] [Abstract][Full Text] [Related]
19. Evolution of Body Composition Following Autologous and Allogeneic Hematopoietic Cell Transplantation: Incidence of Sarcopenia and Association with Clinical Outcomes.
DeFilipp Z; Troschel FM; Qualls DA; Li S; Kuklinski MW; Kempner ME; Hochberg E; Chen YB; El-Jawahri A; Fintelmann FJ
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1741-1747. PubMed ID: 29496561
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation.
Bansal R; Park H; Taborda CC; Gordillo C; Mapara MY; Assal A; Uhlemann AC; Reshef R
Transplant Cell Ther; 2022 Mar; 28(3):135-144. PubMed ID: 34958974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
